China Drugs for the Treatment of Asthma Market Report to 2021

November 2016 | 105 pages | ID: CE7334906BFEN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Drugs for the Treatment of Asthma

Revenue, means the sales value of Drugs for the Treatment of Asthma

This report studies sales (consumption) of Drugs for the Treatment of Asthma in China market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Novartis
• Pfizer, Inc.
• Roche
• Sanofi
• Merck & Co., Inc.
• GlaxoSmithKline plc
• Johnson & Johnson
• AstraZeneca plc.
• Eli Lilly and Company
• Abbvie
• AMGen
• Teva Pharmaceutical Industries Ltd.
• Bayer AG
• Bristol-Myers Squibb
• Astellas Pharma
• Daiichi Sankyo
• Abbott Laboratories
• Yangtze River Pharmaceutical Group
• BAX
• Taishō Seiyaku Kabushiki-gaisha

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Beta2 Adrenergic Receptor Agonist
• M Cholinergic Receptor Antagonist
• Drugs that Affect Leukotrienes
• Glucocorticoid Drugs
• Phosphodiesterase Inhibitors

Split by applications, this report focuses on sales, market share and growth rate of Drugs for the Treatment of Asthma in each application, can be divided into

• First Level Hospital
• Two Level Hospital
• Three Level Hospital
• Others

Contents

China Drugs for the Treatment of Asthma Market Report 2021

1 DRUGS FOR THE TREATMENT OF ASTHMA OVERVIEW

1.1 Product Overview and Scope of Drugs for the Treatment of Asthma
1.2 Classification of Drugs for the Treatment of Asthma
  1.2.1 Beta2 Adrenergic Receptor Agonist
  1.2.2 M Cholinergic Receptor Antagonist
  1.2.3 Drugs that Affect Leukotrienes
  1.2.4 Glucocorticoid Drugs
  1.2.5 Phosphodiesterase Inhibitors
1.3 Applications of Drugs for the Treatment of Asthma
  1.3.1 First Level Hospital
  1.3.2 Two Level Hospital
  1.3.3 Three Level Hospital
  1.3.4 Others
1.4 China Market Size (Value and Volume) of Drugs for the Treatment of Asthma (2011-2021)
  1.4.1 China Drugs for the Treatment of Asthma Sales, Revenue and Price (2011-2021)
  1.4.2 China Drugs for the Treatment of Asthma Sales and Growth Rate (2011-2021)
  1.4.3 China Drugs for the Treatment of Asthma Revenue and Growth Rate (2011-2021)

2 CHINA DRUGS FOR THE TREATMENT OF ASTHMA COMPETITION BY MANUFACTURERS

2.1 China Drugs for the Treatment of Asthma Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 China Drugs for the Treatment of Asthma Revenue and Share by Manufactures (2015 and 2016)

3 CHINA DRUGS FOR THE TREATMENT OF ASTHMA (VOLUME AND VALUE) BY TYPE

3.1 China Drugs for the Treatment of Asthma Sales and Market Share by Type (2011-2021)
3.2 China Drugs for the Treatment of Asthma Revenue and Market Share by Type (2011-2021)

4 CHINA DRUGS FOR THE TREATMENT OF ASTHMA (VOLUME) BY APPLICATION

5 CHINA DRUGS FOR THE TREATMENT OF ASTHMA MANUFACTURERS ANALYSIS

5.1 Novartis
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Drugs for the Treatment of Asthma Product Type and Technology
    5.1.2.1 Beta2 Adrenergic Receptor Agonist
    5.1.2.2 M Cholinergic Receptor Antagonist
  5.1.3 Drugs for the Treatment of Asthma Sales, Revenue, Price of Novartis (2015 and 2016)
5.2 Pfizer, Inc.
  5.2.1 Company Basic Information,Manufacturing Base and Competitors
  5.2.2 Pharmaceuticals Product Type and Technology
    5.2.2.1 Beta2 Adrenergic Receptor Agonist
    5.2.2.2 M Cholinergic Receptor Antagonist
  5.2.3 Pharmaceuticals Sales, Revenue, Price of Pfizer, Inc. (2015 and 2016)
5.3 Roche
  5.3.1 Company Basic Information,Manufacturing Base and Competitors
  5.3.2 Roche Product Type and Technology
    5.3.2.1 Beta2 Adrenergic Receptor Agonist
    5.3.2.2 M Cholinergic Receptor Antagonist
  5.3.3 Roche Sales, Revenue, Price of Roche (2015 and 2016)
5.4 Sanofi
  5.4.1 Company Basic Information,Manufacturing Base and Competitors
  5.4.2 Eli Lilly and Company Product Type and Technology
    5.4.2.1 Beta2 Adrenergic Receptor Agonist
    5.4.2.2 M Cholinergic Receptor Antagonist
  5.4.3 Sanofi Sales, Revenue, Price of Sanofi (2015 and 2016)
5.5 Merck & Co., Inc.
  5.5.1 Company Basic Information,Manufacturing Base and Competitors
  5.5.2 Merck & Co., Inc. Product Type and Technology
    5.5.2.1 Beta2 Adrenergic Receptor Agonist
    5.5.2.2 M Cholinergic Receptor Antagonist
  5.5.3 Merck & Co., Inc. Sales, Revenue, Price of Merck & Co., Inc. (2015 and 2016)
5.6 GlaxoSmithKline plc
  5.6.1 Company Basic Information,Manufacturing Base and Competitors
  5.6.2 GlaxoSmithKline plc Product Type and Technology
    5.6.2.1 Beta2 Adrenergic Receptor Agonist
    5.6.2.2 M Cholinergic Receptor Antagonist
  5.6.3 GlaxoSmithKline plc Sales, Revenue, Price of GlaxoSmithKline plc (2015 and 2016)
5.7 Johnson & Johnson
  5.7.1 Company Basic Information,Manufacturing Base and Competitors
  5.7.2 Johnson & Johnson Product Type and Technology
    5.7.2.1 Beta2 Adrenergic Receptor Agonist
    5.7.2.2 M Cholinergic Receptor Antagonist
  5.7.3 Johnson & Johnson Sales, Revenue, Price of Johnson & Johnson (2015 and 2016)
5.8 AstraZeneca plc.
  5.8.1 Company Basic Information,Manufacturing Base and Competitors
  5.8.2 AstraZeneca plc. Product Type and Technology
    5.8.2.1 Beta2 Adrenergic Receptor Agonist
    5.8.2.2 M Cholinergic Receptor Antagonist
  5.8.3 AstraZeneca plc. Sales, Revenue, Price of AstraZeneca plc. (2015 and 2016)
5.9 Eli Lilly and Company
  5.9.1 Company Basic Information,Manufacturing Base and Competitors
  5.9.2 Eli Lilly and Company Product Type and Technology
    5.9.2.1 Beta2 Adrenergic Receptor Agonist
    5.9.2.2 M Cholinergic Receptor Antagonist
  5.9.3 Eli Lilly and Company Sales, Revenue, Price of Eli Lilly and Company (2015 and 2016)
5.10 Abbvie
  5.10.1 Company Basic Information,Manufacturing Base and Competitors
  5.10.2 Abbvie Product Type and Technology
    5.10.2.1 Beta2 Adrenergic Receptor Agonist
    5.10.2.2 M Cholinergic Receptor Antagonist
  5.10.3 Abbvie Sales, Revenue, Price of Abbvie (2015 and 2016)
5.11 AMGen
5.12 Teva Pharmaceutical Industries Ltd.
5.13 Bayer AG
5.14 Bristol-Myers Squibb
5.15 Astellas Pharma
5.16 Daiichi Sankyo
5.17 Abbott Laboratories
5.18 Yangtze River Pharmaceutical Group
5.19 BAX
5.20 Taishō Seiyaku Kabushiki-gaisha

6 DRUGS FOR THE TREATMENT OF ASTHMA TECHNOLOGY AND DEVELOPMENT TREND

6.1 Drugs for the Treatment of Asthma Technology Analysis
6.2 Drugs for the Treatment of Asthma Technology Development Trend

7 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Drugs for the Treatment of Asthma
Table Classification of Drugs for the Treatment of Asthma
Figure China Sales Market Share of Drugs for the Treatment of Asthma by Type in 2015
Figure Beta2 Adrenergic Receptor Agonist Picture
Figure M Cholinergic Receptor Antagonist Picture
Figure Drugs that Affect Leukotrienes Picture
Figure Glucocorticoid Drugs Picture
Figure Phosphodiesterase Inhibitors Picture
Table Applications of Drugs for the Treatment of Asthma
Figure China Sales Market Share of Drugs for the Treatment of Asthma by Application in 2015
Figure First Level Hospital Examples
Figure Two Level Hospital Examples
Figure Three Level Hospital Examples
Figure Others Examples
Table China Drugs for the Treatment of Asthma Sales, Revenue and Price (2011-2021)
Figure China Drugs for the Treatment of Asthma Sales and Growth Rate (2011-2021)
Figure China Drugs for the Treatment of Asthma Revenue and Growth Rate (2011-2021)
Table China Drugs for the Treatment of Asthma Sales of Key Manufacturers (2015 and 2016)
Table China Drugs for the Treatment of Asthma Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Drugs for the Treatment of Asthma Sales Share by Manufacturers
Figure 2016 Drugs for the Treatment of Asthma Sales Share by Manufacturers
Table China Drugs for the Treatment of Asthma Revenue by Manufacturers (2015 and 2016)
Table China Drugs for the Treatment of Asthma Revenue Share by Manufacturers (2015 and 2016)
Table 2015 China Drugs for the Treatment of Asthma Revenue Share by Manufacturers
Table 2016 China Drugs for the Treatment of Asthma Revenue Share by Manufacturers
Table China Drugs for the Treatment of Asthma Sales and Market Share by Type (2011-2021)
Table China Drugs for the Treatment of Asthma Sales Share by Type (2011-2021)
Figure Sales Market Share of Drugs for the Treatment of Asthma by Type (2011-2021)
Figure China Drugs for the Treatment of Asthma Sales Growth Rate by Type (2011-2021)
Table China Drugs for the Treatment of Asthma Revenue and Market Share by Type (2011-2021)
Table China Drugs for the Treatment of Asthma Revenue Share by Type (2011-2021)
Figure Revenue Market Share of Drugs for the Treatment of Asthma by Type (2011-2021)
Figure China Drugs for the Treatment of Asthma Revenue Growth Rate by Type (2011-2021)
Table China Drugs for the Treatment of Asthma Sales and Market Share by Application (2011-2021)
Table China Drugs for the Treatment of Asthma Sales Share by Application (2011-2021)
Figure Sales Market Share of Drugs for the Treatment of Asthma by Application (2011-2021)
Figure China Drugs for the Treatment of Asthma Sales Growth Rate by Application (2011-2021)
Table Novartis Basic Information List
Table Drugs for the Treatment of Asthma Sales, Revenue, Price of Novartis (2015 and 2016)
Table Pfizer, Inc. Basic Information List
Table Drugs for the Treatment of Asthma Sales, Revenue, Price of Pfizer, Inc. (2015 and 2016)
Table Roche Basic Information List
Table Drugs for the Treatment of Asthma Sales, Revenue, Price of Roche (2015 and 2016)
Table Sanofi Basic Information List
Table Drugs for the Treatment of Asthma Sales, Revenue, Price of Sanofi (2015 and 2016)
Table Merck & Co., Inc. Basic Information List
Table Drugs for the Treatment of Asthma Sales, Revenue, Price of Merck & Co., Inc. (2015 and 2016)
Table GlaxoSmithKline plc Basic Information List
Table Drugs for the Treatment of Asthma Sales, Revenue, Price of GlaxoSmithKline plc (2015 and 2016)
Table Johnson & Johnson Basic Information List
Table Drugs for the Treatment of Asthma Sales, Revenue, Price of Johnson & Johnson (2015 and 2016)
Table AstraZeneca plc. Basic Information List
Table Drugs for the Treatment of Asthma Sales, Revenue, Price of AstraZeneca plc. (2015 and 2016)
Table Eli Lilly and Company Basic Information List
Table Drugs for the Treatment of Asthma Sales, Revenue, Price of Eli Lilly and Company (2015 and 2016)
Table Abbvie Basic Information List
Table Drugs for the Treatment of Asthma Sales, Revenue, Price of Abbvie (2015 and 2016)
Table AMGen Basic Information List
Table Drugs for the Treatment of Asthma Sales, Revenue, Price of AMGen (2015 and 2016)
Table Teva Pharmaceutical Industries Ltd. Basic Information List
Table Drugs for the Treatment of Asthma Sales, Revenue, Price of Teva Pharmaceutical Industries Ltd. (2015 and 2016)
Table Bayer AG Basic Information List
Table Drugs for the Treatment of Asthma Sales, Revenue, Price of Bayer AG (2015 and 2016)
Table Bristol-Myers Squibb Basic Information List
Table Drugs for the Treatment of Asthma Sales, Revenue, Price of Bristol-Myers Squibb (2015 and 2016)
Table Astellas Pharma Basic Information List
Table Drugs for the Treatment of Asthma Sales, Revenue, Price of Astellas Pharma (2015 and 2016)
Table Daiichi Sankyo Basic Information List
Table Drugs for the Treatment of Asthma Sales, Revenue, Price of Daiichi Sankyo (2015 and 2016)
Table Abbott Laboratories Basic Information List
Table Drugs for the Treatment of Asthma Sales, Revenue, Price of Abbott Laboratories (2015 and 2016)
Table Yangtze River Pharmaceutical Group Basic Information List
Table Drugs for the Treatment of Asthma Sales, Revenue, Price of Yangtze River Pharmaceutical Group (2015 and 2016)
Table BAX Basic Information List
Table Drugs for the Treatment of Asthma Sales, Revenue, Price of BAX (2015 and 2016)
Table Taishō Seiyaku Kabushiki-gaisha Basic Information List
Table Drugs for the Treatment of Asthma Sales, Revenue, Price of Taishō Seiyaku Kabushiki-gaisha (2015 and 2016)